McKesson Newsroom

McKesson Is Maintained at Overweight by Morgan Stanley

Dow Jones12:17 ET

McKesson Analyst Ratings

Benzinga12:07 ET

Morgan Stanley Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $642

Moomoo NewsDec 17 09:34 ET

McKesson Is Maintained at Equal-Weight by Wells Fargo

Dow JonesDec 13 12:44 ET

McKesson Analyst Ratings

BenzingaDec 13 12:34 ET

Wells Fargo Initiates McKesson(MCK.US) With Hold Rating, Announces Target Price $641

Moomoo NewsDec 13 07:31 ET

BofA Securities Maintains McKesson(MCK.US) With Buy Rating

Moomoo NewsDec 9 09:33 ET

Leerink Partners Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $667

Moomoo NewsDec 6 01:32 ET

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Revvity (RVTY) and McKesson (MCK)

TipRanksDec 6 01:03 ET

McKesson Assumed With a Neutral at Mizuho

TipRanksDec 3 16:24 ET

Jefferies Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $715

Moomoo NewsNov 20 08:33 ET

Jefferies Sticks to Its Buy Rating for McKesson (MCK)

TipRanksNov 20 08:01 ET

J.P. Morgan Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $708

Moomoo NewsNov 19 07:33 ET

J.P. Morgan Sticks to Their Buy Rating for McKesson (MCK)

TipRanksNov 19 07:09 ET

JPMorgan Adjusts Price Target on McKesson to $708 From $661, Maintains Overweight Rating

MT NewswiresNov 19 06:24 ET

McKesson Analyst Ratings

BenzingaNov 13 12:57 ET

Citi Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $713

Moomoo NewsNov 13 07:33 ET

Analysts Conflicted on These Healthcare Names: McKesson (MCK), Fate Therapeutics (FATE) and Voyager Therapeutics (VYGR)

TipRanksNov 13 05:42 ET

Argus Adjusts Price Target on McKesson to $660 From $570

MT NewswiresNov 12 14:13 ET

Barclays Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $668

Moomoo NewsNov 9 03:34 ET